These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23228630)

  • 41. Contrast-enhanced sonography of a hepatocellular carcinoma undergoing spontaneous necrosis.
    Giannetti A; Corsetti M; Quaranta S; Franci L
    J Clin Ultrasound; 2008 Oct; 36(8):492-6. PubMed ID: 18663752
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of local recurrence after treatment for hepatocellular carcinoma by contrast-enhanced ultrasonography using Sonazoid: comparison with dynamic computed tomography.
    Shiozawa K; Watanabe M; Takayama R; Takahashi M; Wakui N; Iida K; Sumino Y
    J Clin Ultrasound; 2010 May; 38(4):182-9. PubMed ID: 20232404
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Poor contrast enhanced ultrasonography! There is no limit to its decline in the diagnosis of hepatocellular carcinoma on cirrhosis!
    Giorgio A; Giorgio V; Matteucci P
    J Hepatol; 2015 Jun; 62(6):1452-3. PubMed ID: 25703081
    [No Abstract]   [Full Text] [Related]  

  • 44. Reply to: ''Poor contrast enhanced ultrasonography! There is no limit to its decline in the diagnosis of hepatocellular carcinoma on cirrhosis!''.
    Forner A; Vilana R; Solé M; Bruix J
    J Hepatol; 2015 Jun; 62(6):1453-4. PubMed ID: 25703082
    [No Abstract]   [Full Text] [Related]  

  • 45. QUIZ HQ 54. Contrast-enhanced ultrasound (CEUS) for the detection and assessment of treatment efficacy in focal liver lesions.
    Gheorghe L; Carabelea A; Vadan R; Becheanu G
    J Gastrointestin Liver Dis; 2009 Dec; 18(4):473-4. PubMed ID: 20076821
    [No Abstract]   [Full Text] [Related]  

  • 46. Using contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma - what we have and have not achieved.
    Strobel D
    Ultraschall Med; 2021 Apr; 42(2):120-124. PubMed ID: 33845488
    [No Abstract]   [Full Text] [Related]  

  • 47. Malignant portal vein thrombosis.
    Aladlouni S; Arrivé L
    Gastroenterol Clin Biol; 2010 Oct; 34(10):508. PubMed ID: 20692781
    [No Abstract]   [Full Text] [Related]  

  • 48. [Enhanced color flow findings in small hepatocellular carcinoma].
    Maruyama H; Matsutani S; Ebara M; Saisho H
    Nihon Rinsho; 1998 Apr; 56(4):967-74. PubMed ID: 9577618
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of liver lesions by real-time contrast-enhanced ultrasonography.
    Celli N; Gaiani S; Piscaglia F; Zironi G; Camaggi V; Leoni S; Righini R; Bolondi L
    Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):3-14. PubMed ID: 17206071
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Liver tumor as incidental ultrasound finding].
    Görtz RS; Strobel D
    MMW Fortschr Med; 2010 Jan; 152(3):41-3. PubMed ID: 20333967
    [No Abstract]   [Full Text] [Related]  

  • 51. Education and imaging. Hepatobiliary and Pancreatic: Detection of early hepatocellular carcinoma by enhanced magnetic resonance imaging.
    Eso Y; Marusawa H; Osaki Y
    J Gastroenterol Hepatol; 2012 Feb; 27(2):416. PubMed ID: 22260287
    [No Abstract]   [Full Text] [Related]  

  • 52. Changes in tumor vascularity precede microbubble contrast accumulation deficit in the process of dedifferentiation of hepatocellular carcinoma.
    Maruyama H; Takahashi M; Ishibashi H; Okabe S; Yoshikawa M; Yokosuka O
    Eur J Radiol; 2010 Jul; 75(1):e102-6. PubMed ID: 19783392
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Contrast ultrasonography with carbon dioxide in evaluating hepatocellular carcinoma].
    Naito A; Nakanishi T; Azuma K; Ito K
    Nihon Rinsho; 1991 Aug; 49(8):1746-50. PubMed ID: 1664875
    [No Abstract]   [Full Text] [Related]  

  • 54. Hepatocellular nodules in liver cirrhosis: contrast-enhanced ultrasound.
    Kim TK; Lee KH; Khalili K; Jang HJ
    Abdom Imaging; 2011 Jun; 36(3):244-63. PubMed ID: 21253723
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reply to "Application of contrast-enhanced intraoperative ultrasonography in the decision-making about hepatocellular carcinoma operation".
    Donadon M; Torzilli G
    World J Gastroenterol; 2010 Aug; 16(30):3857-8. PubMed ID: 20698051
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Value of wash-in and wash-out time in the diagnosis between hepatocellular carcinoma and other hepatic nodules with similar vascular pattern on contrast-enhanced ultrasound.
    Kong WT; Wang WP; Huang BJ; Ding H; Mao F
    J Gastroenterol Hepatol; 2014 Mar; 29(3):576-80. PubMed ID: 24118042
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Percutaneous ablation therapy guided by contrast-enhanced sonography for patients with hepatocellular carcinoma.
    Numata K; Isozaki T; Ozawa Y; Sakaguchi T; Kiba T; Kubota T; Ito A; Sugimori K; Shirato K; Morimoto M; Tanaka K
    AJR Am J Roentgenol; 2003 Jan; 180(1):143-9. PubMed ID: 12490493
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transabdominal ultrasound with echoenhancement by contrast media in the diagnosis of hepatocellular carcinoma.
    Schacherer D; Girlich C; Jung ME; Wiest R; Scholmerich J
    Dig Dis; 2009; 27(2):109-13. PubMed ID: 19546548
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Early diagnosis of hepatocellular carcinoma using ultrasonography].
    Saito A
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():243-7. PubMed ID: 11761947
    [No Abstract]   [Full Text] [Related]  

  • 60. Usefulness of the post-vascular phase of contrast-enhanced ultrasonography with sonazoid in the evaluation of gross types of hepatocellular carcinoma.
    Hatanaka K; Chung H; Kudo M; Haji S; Minami Y; Maekawa K; Hayaishi S; Nagai T; Takita M; Kudo K; Ueda T; Tatsumi C; Kitai S; Ishikawa E; Yada N; Inoue T; Hagiwara S; Ueshima K
    Oncology; 2010 Jul; 78 Suppl 1():53-9. PubMed ID: 20616585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.